AlloVir, Inc. (ALVR) earnings
Quarterly and annual ALVR reports and results, each read against the price at its own news timestamp. Back to the ALVR overview →
13 measured ALVR earnings events.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q Kalaris Therapeutics, For: Jun 30 | SEC filing · Form 10-Q | — | — | |
| Form 10-Q Kalaris Therapeutics, For: Mar 31 | SEC filing · Form 10-Q | — | — | |
| Form 10-K Kalaris Therapeutics, For: Dec 31 | SEC filing · Form 10-K | — | — | |
| Form 10-Q Kalaris Therapeutics, For: Sep 30 | SEC filing · Form 10-Q | — | — | |
| Form 10-Q Kalaris Therapeutics, For: Jun 30 | SEC filing · Form 10-Q | — | — | |
| Form 10-Q Kalaris Therapeutics, For: Mar 31 | SEC filing · Form 10-Q | — | — | |
| Form 10-K Allovir, Inc. For: Dec 31 | SEC filing · Form 10-K | — | +2.39% | |
| Form 10-Q Allovir, Inc. For: Sep 30 | SEC filing · Form 10-Q | +3.70% | +4.33% | |
| Form 10-Q Allovir, Inc. For: Jun 30 | SEC filing · Form 10-Q | +0.16% | -3.11% | |
| Form 10-Q Allovir, Inc. For: Mar 31 | SEC filing · Form 10-Q | +4.79% | +6.48% | |
| Form 10-K Allovir, Inc. For: Dec 31 | SEC filing · Form 10-K | +0.69% | +12.82% | |
| AlloVir Reports Third Quarter 2023 Financial Results | Press release | +1.25% | +9.38% | |
| Form 10-Q Allovir, Inc. For: Sep 30 | SEC filing · Form 10-Q | +4.29% | -4.00% |
Keep exploring
More ALVR: analyst actions → · SEC filings → · ALVR overview →